DL-Homocysteine CAS:454-29-5

DL-Homocysteine plays a pivotal role in biochemical research, particularly in studies focused on elucidating the pathways and mechanisms involved in homocysteine metabolism, cardiovascular health, and neurological disorders. Its utilization contributes to the exploration of molecular interactions, disease etiology, and potential therapeutic targets related to homocysteine imbalances, providing insights into conditions such as homocystinuria and cardiovascular disease. In clinical diagnostics, DL-Homocysteine is employed as a standard reference material for the quantification of homocysteine levels in biological samples, aiding in the assessment of patient health, risk stratification, and disease management. Its use supports accurate diagnostic assays and laboratory testing aimed at identifying individuals at risk of homocysteine-related complications, such as cardiovascular events or neurological disorders. Furthermore, in pharmaceutical development, DL-Homocysteine may be utilized in the synthesis, characterization, and evaluation of drug compounds targeting conditions associated with homocysteine dysregulation. Its involvement in these processes supports the discovery and validation of potential therapeutic agents for addressing metabolic imbalances and related health issues. Overall, DL-Homocysteine's multifaceted applications in research, clinical diagnostics, and pharmaceutical development underscore its critical role in advancing our understanding of metabolic disorders and the potential development of targeted interventions for improved patient care and management.